MedTrace Logo

Does Testosterone Improve Function in Hypogonadal Older Men

NCT00304213 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-02-13

No results posted yet for this study

Summary

This is a randomized controlled trial of testosterone replacement therapy in hypogonadal men age \> 60 years. The goal is to assess the safety and efficacy of TRT in men age \> 60 years.

Conditions

  • Hypogonadism

Interventions

DRUG

Testosterone

Sponsors & Collaborators

  • Solvay Pharmaceuticals

    collaborator INDUSTRY

  • North Florida Foundation for Research and Education

    lead OTHER

Principal Investigators

  • Thomas Mulligan, MD · Director, GRECC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304213 on ClinicalTrials.gov